OneOncology Sale to TPG and AmerisourceBergen Corporation

We served as lead healthcare regulatory counsel to General Atlantic portfolio company, OneOncology, a leading community oncology practice network, in its agreement to sell a majority interest to TPG (NASDAQ: TPG), a global alternative asset management firm, and AmerisourceBergen Corporation (NYSE: ABC), a leading global pharmaceutical solutions organization for approximately $2.1 billion.

We served as lead healthcare regulatory counsel to General Atlantic portfolio company, OneOncology, a leading community oncology practice network, in its agreement to sell a majority interest to TPG (NASDAQ: TPG), a global alternative asset management firm, and AmerisourceBergen Corporation (NYSE: ABC), a leading global pharmaceutical solutions organization for approximately $2.1 billion.